Barriers to adherence to COPD guidelines among primary care providers  by Perez, Xavier et al.
Respiratory Medicine (2012) 106, 374e381Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate /rmedBarriers to adherence to COPD guidelines among
primary care providersXavier Perez a, Juan P. Wisnivesky a, Linda Lurslurchachai a,
Lawrence C. Kleinman b, Ian M. Kronish c,*aDivision of General Internal Medicine, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1087, New York,
NY 10029, United States
bDepartment of Health Policy, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1087, New York,
NY 10029, United States
cDivision of General Medicine, Columbia University, 622 West 168th Street, PH9-311, Columbia University Medical Center,
New York, NY 10032, United States
Received 13 July 2011; accepted 22 September 2011
Available online 13 October 2011KEYWORDS
COPD;
Guidelines;
Adherence;
Primary care* Corresponding author. Tel.: þ1 21
E-mail address: ik2293@columbia.
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2011.09.010Summary
Background: Despite efforts to disseminate guidelines for managing chronic obstructive pulmo-
nary disease (COPD), adherence to COPD guidelines remains suboptimal. Barriers to adhering
to guidelines remain poorly understood.
Methods: Clinicians from two general medicine practices in New York City were surveyed to
identify barriers to implementing seven recommendations from the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) guidelines. Barriers assessed included unfamiliarity,
disagreement, low perceived benefit, low self-efficacy, and time constraints. Exact conditional
regression was used to identify barriers independently associated with non-adherence.
Results: The survey was completed by 154 clinicians. Adherence was lowest to referring
patients with a forced expiratory volume in 1 s (FEV1) <80% predicted to pulmonary rehabili-
tation (5%); using FEV1 to guide management (12%); and ordering pulmonary function tests
(PFTs) in smokers (17%). Adherence was intermediate to prescribing inhaled corticosteroids
when FEV1 <50% predicted (41%) and long-acting bronchodilators when FEV1 <80% predicted
(54%). Adherence was highest for influenza vaccination (90%) and smoking cessation counseling
(91%). In unadjusted analyses, low familiarity with the guidelines, low self-efficacy, and time
constraints were significantly associated with non-adherence to 2 recommendations. In
adjusted analyses, low self-efficacy was associated with less adherence to prescribing inhaled
corticosteroids (OR: 0.28; 95% CI: 0.10, 0.74) and time constraints were associated with less
adherence to ordering PFTs in smokers (OR: 0.31; 95% CI: 0.08, 0.99).2 342 1335; fax: þ1 212 305 0312.
edu (I.M. Kronish).
1 Elsevier Ltd. All rights reserved.
Adherence to COPD guidelines 375Conclusions: Poor familiarity with recommendations, low self-efficacy, and time constraints
are important barriers to adherence to COPD guidelines. This information can be used to
develop tailored interventions to improve guideline adherence.
ª 2011 Elsevier Ltd. All rights reserved.Background
Chronic obstructive pulmonary disease (COPD) is a highly
prevalent disease that is projected to become the third
leading cause of mortality worldwide by 20201,2 and that
results in considerable health care expenditures with an
estimated annual cost of $50 billion in the United States,
alone.3 To standardize treatment for COPD, an interna-
tional group of experts in conjunction with the World
Health Organization and the National Heart, Lung and Blood
Institute (NHLBI) developed the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) in 1997. The main purpose
of this project was to create and disseminate guidelines
that would help prevent COPD and would establish a stan-
dard of care for treating patients with COPD based on the
most current medical evidence.4 The GOLD guidelines, last
updated in 2010, are widely recognized by professional
medical organizations in the US and internationally as the
most complete and up-to-date source of information
regarding COPD care.5
Even though the GOLD Dissemination Committee has
made major efforts to increase awareness of the guide-
lines, studies suggest that the adoption of the GOLD
guidelines has been suboptimal.6e9 For example, in
a recent study of 200 individuals treated at a family
medicine clinic, only 50% of patients diagnosed as having
COPD ever underwent pulmonary function tests (PFT) to
confirm the presence of airway obstruction disease and only
40% received stage appropriate medications.8 While several
studies have examined rates of non-adherence to the GOLD
guidelines, few have examined physician barriers to
adherence to the GOLD guidelines. This study was designed
to assess the barriers to adherence to the GOLD guidelines
for the outpatient management of COPD among primary
care providers (PCPs), a group that provides approximately
80% of the care to patients with COPD in the US.Methods
Our study population consisted of PCPs from hospital-based
practices affiliated with Mount Sinai Medical Center, a large
academic hospital, and North General Hospital, a commu-
nity hospital. Both practices are located in East Harlem,
New York, a community with a large population of under-
served low-income and minority patients. PCPs were
eligible for this study if they provided direct care to
patients with COPD at either of these practices. Eligible
PCPs were identified from clinic rosters; physicians-in-
training were eligible once they had completed at least
six months of internal medicine residency. No pulmonary
specialists were recruited for this study. The study protocolwas approved by the Institutional Review Boards of the
Mount Sinai School of Medicine and North General Hospital.Survey instrument
A standardized, self-administered questionnaire was used
to collect information about provider sociodemographics,
year of graduation, number of COPD patients seen in the
outpatient setting in a “typical” month, level of training
(faculty vs. trainee), and whether the provider had a family
history of COPD. Providers were asked to report their
adherence to seven COPD management practices recom-
mended by the GOLD guidelines that are essential to quality
outpatient COPD care and are recommended by the GOLD
guidelines (Fig. 1). Specifically, PCPs were asked whether
they ordered PFTs or spirometry to diagnose COPD in
smokers; used forced expiratory volume in 1 s (FEV1) to
guide treatment of COPD; prescribed inhaled corticoste-
roids for COPD patients with an FEV1 <50% predicted;
prescribed long-acting bronchodilators for COPD patients
with FEV1 <80% predicted; offered pulmonary rehabilita-
tion for COPD patients with FEV1 <80% predicted; coun-
seled on smoking cessation; and offered annual influenza
vaccination. Providers reported whether they were
adherent to each guideline component 0%, 1%e25%, 26%e
50%, 51%e75%, 76%e99%, or 100% of the time. Providers
who reported following a practice >75% of the time were
classified as adherent to that recommendation; other
providers were classified as non-adherent.10,11
Barriers to guideline adherence were assessed using the
theoretical model of Knowledge, Attitude, and
Behavior.12,13 According to this model, for guidelines to be
incorporated into everyday practice, a series of internal
barriers (directly related to the provider) and external
barriers (outside the provider’s control) need to be over-
come. Internal barriers are considered to affect provider
adherence through the cognitive and affective components
of knowledge and attitudes. To assess knowledge, we asked
providers whether they had heard about and/or had read
the GOLD guidelines. In addition, irrespective of whether
they had heard or read the GOLD guidelines, we asked them
to rate their familiarity with each of the seven recom-
mendations listed in the guidelines. Familiarity was
assessed with a 4-point Likert Scale ranging from 1 (not
familiar) to 4 (very familiar).
According to the model of Knowledge, Attitudes, and
Behavior, physicians acquire information about caring for
patients with COPD from multiple sources (e.g., supervi-
sors, textbooks, peers) and guidelines represent just one
source. Hence, physicians may still hold attitudes about
specific COPD management practices even if they lack
knowledge that these practices are recommended by
1. “Considering all of your patients who smoke, for what percentage of them who complain of shortness of breath do you
 order a pulmonary function test or obtain a spirometry test?”
2. “Considering all of your patients with COPD, for what percentage of them do you use predicted force expiratory volume 
in one second (FEV1) to guide your medical treatment?”
3. “Considering all of your COPD patients with an FEV1<50% of predicted, for what percentage of them do you prescribe a 
daily inhaled corticosteroid?”
4. “Considering all of your COPD patients with an FEV1<80% of predicted, for what percentage of them do you prescribe a 
long acting bronchodilator like triotropium or salmeterol?”
5. “For what percentage of your COPD patients with FEV1<80% of predicted do you offer pulmonary rehabilitation?”
6. “For what percentage of your COPD patients who are currently smoking do you counsel on smoking cessation?”
7. “For what percentage of your patients with COPD do you offer annual influenza vaccination?”
Figure 1 Survey items assessing adherence to seven Chronic Obstructive Pulmonary Disease (COPD) management practices
recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Abbreviations: FEV1, forced expi-
ratory volume in one second.
376 X. Perez et al.specific guidelines. Accordingly, we asked all providers
about their attitudes toward practices recommended by
the guidelines irrespective of their knowledge about the
GOLD guidelines. Specifically, providers were asked to rate
1) their level of agreement with each recommended prac-
tice; 2) their perception of the benefit of performing each
practice; and 3) their self-efficacy for performing each
recommendation. Self-efficacy refers to the belief that one
can actually perform a behavior. Providers were asked to
rate their responses using 4-point Likert scales for 1) level
of agreement (completely disagree to completely agree), 2)
perception of benefit (no benefit to large benefit), and 3)
self-efficacy (not at all confident to very confident). To
assess external workplace-related barriers, we asked
providers how much their ability to follow each recom-
mendation was limited by time constraints using a 4-point
Likert scale (very limiting to not limiting).
When assessing attitudes and time constraints, providers
were given a description of each recommended practice so
that they could rate their responses to these items even if
they lacked familiarity with the fact that the practice was
recommended by the GOLD guidelines. For analytic
purposes, responses were dichotomized and, according to
convention,11,14 a barrier was coded as present if a provider
answered 2 on the corresponding Likert scale.Statistical analysis
We used the chi-square or Fisher exact test, when appro-
priate, to test whether the barriers identified by the
conceptualmodel (lack of familiarity, disagreementwith the
guidelines, lowperceivedbenefit, lowself-efficacy, and time
constraints) were individually associated with providers’
self-reported adherence toeach guideline component. Exact
conditional logistic regression analysis was used to assess
whether specific barriers were independently associated
with adherence to the guidelines after controlling for COPD
patient volume. In secondary analyses, we adjusted our
model for provider type (faculty vs trainee). Multivariable
analyses were not conducted to assess barriers to offeringinfluenza vaccination and counseling on smoking cessation as
a very small number of providers were non-adherent to these
recommendations. Multivariable analyses were also not
conducted to assess barriers to offering pulmonary rehabili-
tation as very few providers were adherent to this recom-
mendation. Analyses were conducted with SAS version 9
statistical software (SAS Institute Inc, Cary, North Carolina).Results
A total of 162 primary care providers were invited to
participate in the study, of which 154 (95%) completed the
survey (Table 1). The mean age of providers was 30 years;
57% were White; and 69% were internal medicine residents.
There were no significant differences in the proportion of
trainees and faculty who were aware of (50% vs 44%,
respectively, p Z 0.57) or who had read these guidelines
(39% vs 37%, respectively, p Z 0.81).
Rates of self-reported adherence to the seven outpa-
tient practice recommendations evaluated in this study are
shown in Fig. 2. Rates of adherence were relatively low to
several practices including: 1) ordering PFTs or spirometry
in smokers with shortness of breath (17%); 2) using FEV1 to
guide medical treatment in patients with COPD (12%); and
3) referring patients with FEV1 <80% predicted to pulmo-
nary rehabilitation (5%). In contrast, there was high
adherence to smoking cessation counseling (91%) and
offering influenza vaccination (90%) for patients with COPD.
Adherence was intermediate to prescribing inhaled corti-
costeroids to patients with FEV1 <50% predicted (41%) and
long-acting bronchodilators to patients with FEV1 <80%
predicted (54%). There were no significant associations
between provider type and adherence to any of the specific
guideline recommendations.
The pattern of barriers differed for each of the seven
recommendations (Fig. 2). For influenza vaccination, none
of the barriers was present for more than 15% of clinicians.
In contrast, for the recommendation to offer pulmonary
rehabilitation to all patients with an FEV1 <80% predicted,
each of the barriers was present for at least 30% of
Figure 2 Rates of adherence and prevalence of barriers to guide
volume in one second; PFTs, pulmonary function tests; LABA, long
Table 1 Characteristics of providers caring for patients
with chronic obstructive pulmonary disease (N Z 154).a
Characteristic
Age in years, mean (SD) 30 (7)
Male, No (%) 78 (53)
Race, No (%)
White 85 (57)
Asian 45 (30)
Black 13 (9)
Other 7 (5)
Ethnicity, No (%)
Hispanic 10 (7)
Level of training, No (%)
Resident 107 (70)
Facultyb 45 (30)
Years since completing
professional school, mean (SD)
7 (7)
Number of outpatients with
COPD seen per month, No (%)
0e5 51 (33)
6e10 58 (38)
11e20 30 (20)
>20 14 (9)
Family history of COPD, No (%) 15 (10)
a Denominators for variables vary slightly due to missing
responses. Fewer than 5% of responses were missing for these
variables. Percentages may not add up to 100% as a result of
rounding.
b Includes 2 nurse practitioners.
Adherence to COPD guidelines 377providers. Qualitatively, a higher overall prevalence of
barriers was associated with lower adherence to guidelines.Association between barriers to adherence and
specific recommendations
Several internal barriers were associated with non-
adherence to specific GOLD guideline recommendations
(Table 2). Lack of familiarity with specific recommenda-
tions was associated with non-adherence to prescribed
inhaled corticosteroids for patients with FEV1 <50% pre-
dicted (p Z 0.01) and to prescribing long-acting broncho-
dilators for patients with FEV1 <80% predicted (pZ 0.007).
Low self-efficacy was associated with non-adherence to
prescribing inhaled corticosteroids for patients with FEV1
<50% predicted, (p < 0.001), prescribing long-acting
bronchodilators for patients with FEV1 <80% predicted
(p Z 0.04), and offering pulmonary rehabilitation to
patients with FEV1 <80% predicted (p Z 0.01). Lack of
perceived benefit was only associated with low adherence
to ordering influenza vaccination (p < 0.001). Disagreement
with the guidelines and not knowing of their existence were
not barriers (p > 0.05) to adhering to any of the seven
guideline components evaluated in this study.
The external barrier of time constraints was associated
with non-adherence to ordering PFTs or spirometry on
smokers who complain of shortness of breath (p Z 0.007)
and with offering influenza vaccination (p < 0.001). There
was no association between the volume of COPD patients
and any of the barriers or recommendations evaluated.line recommendations. Abbreviations: FEV1, forced expiratory
-acting beta-agonists.
2 Univariate Associations between Barriers to Adopting Guidelines and Adherence to Practices Recommended Global Initiative for Chronic Obstructive Lung
e Guidelines.
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Adjusted analysis showed that low self-efficacy in
prescribing inhaled corticosteroids for COPD patients with
FEV1 <50% predicted was a significant barrier in the fully
adjusted model; providers who lacked confidence in their
ability to perform this task were less adherent to
prescribing corticosteroids according to PFT results
compared to physicians who did not report this barrier (OR:
0.28; 95% CI: 0.10, 0.74). In addition, time constraints
remained a significant barrier to performing PFTs to guide
COPD treatment in smokers. Providers who reported time
constraints as a barrier were less likely to adhere to PFTs
than those who did not have this barrier (OR: 0.31; 95% CI:
0.08, 0.99). None of the other barriers including volume of
COPD patients remained significant after testing them in
the fully adjusted models (Table 3). Additional analyses
(data not shown) that substituted volume of COPD patients
with provider type (faculty vs trainee) did not significant
alter any of the associations between barriers and adher-
ence to selected COPD practices.Discussion
In this study, we found that PCPs’ adherence to GOLD
guidelines was relatively poor, with <60% of providers being
adherent to five of the seven assessed outpatient guideline
recommendations. One important barrier identified in this
study was low familiarity with specific recommendations of
the GOLD guidelines. Low familiarity was associated with
lower adherence to three of the guideline components on
univariate analyses. Lack of adequate training in COPD
management likely contributes to low familiarity. In a study
of PCPs attending a respiratory conference, one in four
respondents reported inadequate training in the manage-
ment of COPD.6 Other studies have shown that medical
students do not receive sufficient training in the interpre-
tation of PFTs or in the diagnosis of COPD.15e17 In our study,
even though the GOLD guidelines were first published more
than a decade ago, less than half of respondents were awareTable 3 Exact Conditional Logistic Regression Models of Primary
Barriers PFTs or spirometry
for smokers OR (95% CI)
FEV1
thera
Unfamiliar with specific
recommendation
0.92 (0.25  3.15) 0.45
Disagree with specific
recommendation
0.99 (0.09  6.19) .
Low self-efficacy for performing
specific recommendation
0.30 (0.03  1.59) 0.44
Low perceived benefit of specific
recommendation
2.42 (0.44  11.98) 1.21
Time limits ability to perform
specific recommendation
0.31y (0.08  0.99) 0.39
Low volume of COPD patients 2.00 (0.60  6.65) 1.69
* Abbreviations: COPD, chronic obstructive pulmonary disease; PFT,
second; LABA, long-acting beta agonist; OR, odds ration; CI, confiden
y p<0.05.of their existence and even fewer had read them. Hence,
there may need to be greater resources dedicated to
increasing awareness of the GOLD guidelines.
Another important barrier to the implementation of the
GOLD guidelines among the PCPs surveyed in this study was
low self-efficacy. This barrier remained present even after
adjusting for low familiarity in one of the multivariable
models. Low self-efficacy has previously been identified as
an important barrier to implementing guidelines for the
treatment of asthma.11 Each of the recommended practices
for which low self-efficacy was associated with low adher-
ence required interpreting PFTs and then recommending
treatments based on these interpretations. Hence, low self-
efficacy may reflect providers’ lack of confidence in their
ability to interpret PFTs and/or to evaluate and counsel
patients about the potential benefits, side-effects and
adverse consequences of treatments to be recommended on
the basis of PFTs. Interventions that aim to improve self-
efficacy, such as the Institute for Health care Improve-
ment’s Breakthrough Series (BTS), might be appropriate to
improve adherence to theGOLD guidelines.18 BTSmodels are
short-term (6- to 15-month) learning systems that bring
together a large number of teams from hospitals or clinics
with the intention to educate providers, and allow clinicians
to implement and sustain practice changes. In one study of 18
practices that utilized the BTS model, rates of adherence to
several of the GOLD guideline recommendations increased
during a three year period.19
Providers who felt limited by time were less likely to
order PFTs or spirometry to diagnose COPD in smokers.
Studies evaluating possible causes of underuse of PFTs have
found that lack of availability was a key issue.20,21 Yet, in
this study, all clinicians had access to PFTs through their
hospitals. Hence, it appears that just having access to PFT
testing is insufficient for overcoming this barrier. It is
possible that clinicians felt constrained by the amount of
time it would take to interpret PFT results or to explain the
rationale and results of PFTs to smokers. Alternatively,
even though these tests were available at each practice, it
is possible that there were barriers to ordering the test or
obtaining results. Facilitating the delivery of PFT resultsCare Physician Adherence to 4 COPD Guideline Components.*
to guide
py OR (95% CI)
Inhaled corticosteroids
if FEV1<50% OR (95% CI)
LABA if FEV1<80%
OR (95% CI)
(0.06  2.43) 0.62 (0.23  1.71) 0.45 (0.15  1.33)
0.28 (0.02  2.46) 0.44 (0.11  1.54)
(0.05  2.84) 0.28y (0.10  0.74) 0.61 (0.22  1.70)
(0.11  8.12) 3.46 (0.47  46.84) 1.17 (0.15  7.17)
(0.08  1.54) 0.76 (0.15  3.96) 1.26 (0.28  5.36)
(0.39  6.83) 1.49 (0.59  3.88) 1.07 (0.43  2.63)
pulmonary function test; FEV1, forced expiratory volume in one
ce interval.
380 X. Perez et al.with clear interpretation from pulmonary specialists may
improve adherence to this guideline by PCPs. Time
constraints were also associated with less adherence to
offering influenza vaccination. To maximize adherence to
this guideline, primary care practices might consider
enlisting nurses or other members of the health care team
to ensure this practice is universally implemented.
Pulmonary rehabilitation is a non-pharmacological
intervention that has been consistently shown to decrease
dyspnea and improve quality of life in patients with
COPD.22,23 Adherence to this recommendation was very low
(5%) among providers in this study and low self-efficacy was
significantly associated with non-adherence to this guide-
line. In prior studies, low rate of referral to pulmonary
rehabilitation was attributed to lack of availability of this
service.6,20,24 It is possible that physicians in this study re-
ported low confidence in being able to carry out this
recommendation because they did not know how to refer
patients to pulmonary rehabilitation, either because it was
not available at their institutions or they were unpracticed
at knowing how to access it.
In contrast with pulmonary rehabilitation, rates of
adherence to smoking cessation counseling and influenza
vaccination were high (90%). Both of these recommenda-
tions have been part of quality improvement interventions
and broad public health campaigns independent of their
relationship to COPD. Although 90% adherence is high, some
might argue that this is still suboptimal. A larger sample size
would be needed to assess whether any of the barriers in the
Knowledge, Attitudes, Behavior model are related to
suboptimal adherence to these recommendations.
There are several limitations to the interpretation of our
findings. Providers were enrolled from two practices in New
York City and, hence, providers may not be representative
of other settings. Additionally, a large percentage of
providers were internal medicine residents which limits the
generalizability of the results. Yet, there were no signifi-
cant differences in the proportion of trainees who were
aware of GOLD guidelines or who adhered to the specific
guideline recommendations compared to faculty. Further,
most inner-city patients with COPD receive care in hospital-
based clinics that are routinely staffed by residents. Also,
adherence was based on self-report, and may represent an
overestimate as a result of social desirability bias. Never-
theless, participants were instructed that their responses
would be kept confidential and commonly reported non-
adherence to many recommendations. Furthermore, self-
reported rates of adherence to some recommendations
such as use of long-acting bronchodilators and inhaled
corticosteroids are comparable to those reported in other
national surveys.8,25e27 The choice of cutpoint to deter-
mine adherence was somewhat arbitrary and the selection
of a different cutpoint may have resulted in different
estimates of guideline adherence.
Increasing adherence to GOLD guidelines has the
potential to improve the outcomes of the large number of
COPD patients. Our findings demonstrate that disagreement
with the guidelines and lack of perceived benefit are not
major barriers. Instead, our data suggest that educational
interventions targeted at decreasing unfamiliarity and
increasing self-efficacy for implementing the guidelines can
improve COPD management. Efforts directed at improvingknowledge of PFTs in COPD management and at facilitating
the ordering and interpretation of PFTs have potential for
the greatest impact. Special attention should also be paid
to decreasing barriers to referring appropriate patients to
pulmonary rehabilitation.Acknowledgments
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